Kärkkäinen Satu, Peuhkurinen Keijo
Kuopio University and Kuopio University Hospital, Kuopio, Finland.
Ann Med. 2007;39(2):91-107. doi: 10.1080/07853890601145821.
Dilated cardiomyopathy (DCM) is a myocardial disease characterized by dilatation and impaired systolic function of the left or both ventricles. The etiology of DCM is multifactorial, and many different clinical conditions can lead to the phenotype of DCM. During recent years it has become evident that genetic factors play an important role in the etiology and pathogenesis of idiopathic DCM. The genetics of DCM have been under intensive investigation lately, and thereby the knowledge on the genetic basis of DCM has increased rapidly. The genetic background of the disease seems to be relatively heterogeneous, and the disease-associated mutations concern mostly single families and only few affected patients. Disease-associated mutations have been detected e.g. in genes encoding sarcomere, cytoskeletal, and nuclear proteins, as well as proteins involved with regulation of Ca(2+) metabolism. The mechanisms, by which mutations eventually result in clinical heart failure, are complex and not yet totally resolved. DCM causes considerable morbidity and mortality. Better knowledge of the genetic background and disease-causing mechanisms would probably help us in focusing early treatment on right subjects and potentially also developing new treatment modalities and improving cardiac outcome in the affected patients. This review deals with DCM of genetic origin.
扩张型心肌病(DCM)是一种心肌疾病,其特征为左心室或双心室扩张及收缩功能受损。DCM的病因是多因素的,许多不同的临床情况可导致DCM的表型。近年来,遗传因素在特发性DCM的病因和发病机制中发挥重要作用已变得明显。最近,DCM的遗传学受到了深入研究,因此关于DCM遗传基础的知识迅速增加。该疾病的遗传背景似乎相对异质性,且与疾病相关的突变大多涉及单个家族,仅少数患者受影响。已在例如编码肌节、细胞骨架和核蛋白的基因以及参与钙(Ca2+)代谢调节的蛋白中检测到与疾病相关的突变。突变最终导致临床心力衰竭的机制复杂且尚未完全阐明。DCM导致相当高的发病率和死亡率。更好地了解遗传背景和致病机制可能有助于我们将早期治疗集中于合适的对象,并可能还会开发新的治疗方式以及改善受影响患者的心脏预后。本综述探讨遗传起源的DCM。